BU-NOT-SET

CONTACT US
Optimising excipient selection
  • Drug product
Eyes
Insight
Serialisation stragglers: Industry concern for complacency
  • Manufacturing
Eyes
Insight
The race against the serialisation deadline
  • Manufacturing
Eyes
Insight
Why tomorrow is too late to start your serialisation preparations
  • Manufacturing
Eyes
Insight
The serialisation landscape: Challenges and opportunities for a CDMO
  • Manufacturing
Eyes
Insight
Aseptic manufacturing trends roundtable
  • Industry trends
Eyes
Insight
Developing a high throughput screening method
  • Drug substance
Eyes
Insight
Why outsourcing is key to bringing flexibility and capacity to the manufacture of oral solid dosage forms
  • Manufacturing
Eyes
Insight
Can bigger be better?
  • Industry trends
Eyes
Insight
Insight
  • Biologics
Enhancing the production of RNA with continuous manufacturing
Fact sheet
  • Drug product
GERTEIS MINI-PACTOR® Advanced dry granulation services
Case study
  • Biologics
Overcoming oncolytic virus therapy production challenges through collaboration
Insight
  • Industry trends
Emerging trends set to impact drug development in 2024
Webinar
  • Biologics
Webinar: ATMPs in focus: Essential CMC strategies for every phase
Insight
  • Drug product
  • Industry trends
Trends set to make an impact on oral solid dose development in 2024
Insight
  • Biologics
Enhancing AAV therapy development and manufacture with a platform approach
Insight
  • Drug product
  • Industry trends
Challenges and solutions to enhancing mRNA stability with lyophilisation processes
Insight
  • Industry trends
  • Manufacturing
A well-equipped CDMO for OSD contract manufacturing